Poor Responders in IVF

1

Review clinical trials related to Poor Responders in IVF. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients

Poor ovarian response population of ART are considered the biggest challenge for providers. Hitherto, no one protocol has been proven to be effect in this subgroup of IVF patients. Metoclopramide belongs to the antiemetic group, used for motion sickness and during early gestation for hyperemesis gravidarum. The mechanism of action is antagonisim to dopamine receptors. We hypothesize than by blocking dopamine receptors and decreasing the dopaminergic tone there is a possibility to increase the sensitivity of ovarian response to gonadotropins during controlled ovarian stimulation and result in increased oocyte retrival.

Participants needed: 60
Trial details
Age: 18-54Biological sex: FemaleType: InterventionalSponsor: Barzilai Medical CenterUpdated: Feb 10, 2025Locations: 1
Eligibility criteria

Poor response according to "Bologna criteria"

Allergy to metoclopramide [+2]